(Q40880386)

24 September 2017

1 reference

title

Echocardiography for the assessment of myocardial viability (English)

1 reference

24 September 2017

1 reference

Lualdi JC

1

1 reference

24 September 2017

Douglas PS

series ordinal

2

1 reference

24 September 2017

publication date

1 September 1997

1 reference

Journal of the American Society of Echocardiography

24 September 2017

published in

1 reference

24 September 2017

volume

10

1 reference

24 September 2017

issue

7

1 reference

24 September 2017

page(s)

772-780

1 reference

Results of coronary artery surgery in patients with poor left ventricular function (CASS).

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Improved regional ventricular function after successful surgical revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Reversible segmental left ventricular dysfunction after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

The stunned myocardium: prolonged, postischemic ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Does positron emission tomography improve patient selection for coronary revascularization?

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Clinical importance of viability assessment in chronic ischemic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

The hibernating myocardium: implications for management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Reversibility of cardiac wall-motion abnormalities predicted by positron tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

"Hibernating" myocardium: asleep or part dead?

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the "biphasic" response of wall thickening during low and high dose dobutamine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Preoperative Selection of Patients With Severely Impaired Left Ventricular Function for Coronary Revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Accuracy of dobutamine echocardiography for detection of myocardial viability in patients with an occluded left anterior descending coronary artery

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Myocardial viability: contractile reserve or cell membrane integrity?

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Assessment of coronary microcirculation with myocardial contrast echocardiography: current and future clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Comparison of Myocardial Contrast Echocardiography and Low-Dose Dobutamine Stress Echocardiography in Predicting Recovery of Left Ventricular Function After Coronary Revascularization in Chronic Ischemic Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Infra-low dose dipyridamole test. A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability.

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

Ultrasonic tissue characterization with integrated backscatter. Acute myocardial ischemia, reperfusion, and stunned myocardium in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0894-7317%2897%2970125-1

7 January 2021

10.1016/S0894-7317(97)70125-1

Identifiers

DOI

1 reference

24 September 2017

1 reference